GlassScriptPhysician profile
Kevin I Pak
NPI 1508922527
$520.50
in general payments reported to CMS, 2019-2025
10 companies · $137 in 2025
The $137 reported for 2025 was more than what a typical Sports Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $119).
See the full distribution for Sports Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $187 · 2020: $20.74 · 2022: $23.05 · 2023: $37.79 · 2024: $115 · 2025: $137.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $290.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $289.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mml US, INC. | $251.79 | 2024-2025 | Reactiv8 |
| Depuy Synthes Sales INC. | $87.68 | 2019-2020 | |
| Pacira Therapeutics, INC. | $59.72 | 2019 | |
| Mallinckrodt Hospital Products INC. | $23.08 | 2023 | Terlivaz |
| Janssen Pharmaceuticals, INC | $23.05 | 2022 | |
| Medtronic USA, INC. | $17.50 | 2019 | |
| Fidia Pharma USA INC. | $16.26 | 2019 | |
| Anika Therapeutics, INC. | $15.81 | 2019 | |
| Heron Therapeutics, INC. | $14.71 | 2023 | Zynrelef |
| Amgen INC. | $10.90 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Pak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.